Ranhel C. De Roxas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ranhel C. De Roxas has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Artemio A. Roxas
Department of Neurosciences, Philippine General Hospital, Manila, Philippines
1 shared publicationCarissa P. Dioquino-Maligaso
1 shared publicationEla A. Barcelon
1 shared publication- Ena Elizabeth L. Naoe
Division of Adult Neurology, Department of Neurosciences, College of Medicine and Philippine General Hospital, University of the Philippines Manila, Manila, Philippines
1 shared publication - Gerard Saranza
Department of Neurosciences, University of the Philippines-Philippine General Hospital, Manila, Philippines; Section of Neurology, Department of Internal Medicine, Chong Hua Hospital, Fuente, Cebu, Philippines; Movement Disorders Service, Chong Hua Hospital & Vicente Sotto Memorial Medical Center, Cebu, Philippines; Departments of Anatomy & Internal Medicine, Cebu Institute of Medicine, Cebu, Philippines
1 shared publication Jobelle Joyce Anne R. Baldonado
Department of Surgery, Philippine General Hospital, Manila, Philippines
1 shared publication
Latest Publications
- Open Access
- 29 April 2025
- Published by SAGE Publications in Sage Open Medical Case Reports
- Vol. 13
Anti-glutamic acid decarboxylase 65: Related stiff person syndrome – A report of two cases and literature review
Stiff person syndrome is a rare neurological disorder characterized by muscular rigidity, painful spasms, and gait abnormalities. The diagnosis is primarily clinical and often requires a high index of suspicion. While the pathophysiology is not fully understood, stiff person syndrome is frequently associated with anti-glutamic acid decarboxylase 65 antibodies, and in some cases, paraneoplastic syndromes. We present two cases of anti-glutamic acid decarboxylase 65positive stiff person syndrome in the Philippines: a 53-year-old diabetic woman presenting with a classical stiff person syndrome case that responded well to symptomatic treatment, and a 62-year-old woman with a history of thyroiditis presenting with paraneoplastic stiff person syndrome that showed significant improvement on follow up after plasmapheresis and tumor excision. These cases are particularly valuable due to their rare local presentation, contributing to the limited data on stiff person syndrome in our region. This article also includes a review of the existing literature on stiff person syndrome, highlighting key diagnostic and therapeutic approaches. The findings emphasize the importance of early diagnosis and intervention, as well as expanding clinical awareness of this condition in regions where it is not widely recognized.
- 29 April 2025
- Published by SAGE Publications in Sage Open Medical Case Reports
- Vol. 13
Open AccessAnti-glutamic acid decarboxylase 65: Related stiff person syndrome – A report of two cases and literature review
Stiff person syndrome is a rare neurological disorder characterized by muscular rigidity, painful spasms, and gait abnormalities. The diagnosis is primarily clinical and often requires a high index of suspicion. While the pathophysiology is not fully understood, stiff person syndrome is frequently associated with anti-glutamic acid decarboxylase 65 antibodies, and in some cases, paraneoplastic syndromes. We present two cases of anti-glutamic acid decarboxylase 65positive stiff person syndrome in the Philippines: a 53-year-old diabetic woman presenting with a classical stiff person syndrome case that responded well to symptomatic treatment, and a 62-year-old woman with a history of thyroiditis presenting with paraneoplastic stiff person syndrome that showed significant improvement on follow up after plasmapheresis and tumor excision. These cases are particularly valuable due to their rare local presentation, contributing to the limited data on stiff person syndrome in our region. This article also includes a review of the existing literature on stiff person syndrome, highlighting key diagnostic and therapeutic approaches. The findings emphasize the importance of early diagnosis and intervention, as well as expanding clinical awareness of this condition in regions where it is not widely recognized.
- 1 January 2017
- Published by AME Publishing Company in Journal of Xiangya Medicine
- Vol. 2 (2) , 24
Developing an evidence-based clinical algorithm for the assessment, diagnosis and management of acute subarachnoid hemorrhage: a review of literature
Subarachnoid hemorrhage (SAH) is a neurologic emergency with a high mortality rate. To the best of the authors’ knowledge, there is still no complete clinical algorithm in the local setting to guide medical practitioners in the management of this devastating disease. A comprehensive review of literature was conducted on the current relevant evidence on the assessment, diagnosis and management of SAH. Electronic databases (Medline, PubMed, Google Scholar and Herdin) were searched for relevant literature between 1985 and 2015. A total of 40 articles were obtained and were used to develop the evidence-based clinical algorithm for acute SAH. The clinical algorithm was presented in a one of the conference meeting of the Philippine General Hospital Department of Neurosciences for consensus.
- 1 January 2017
- Published by AME Publishing Company in Journal of Xiangya Medicine
- Vol. 2 (2) , 24
Developing an evidence-based clinical algorithm for the assessment, diagnosis and management of acute subarachnoid hemorrhage: a review of literature
Subarachnoid hemorrhage (SAH) is a neurologic emergency with a high mortality rate. To the best of the authors’ knowledge, there is still no complete clinical algorithm in the local setting to guide medical practitioners in the management of this devastating disease. A comprehensive review of literature was conducted on the current relevant evidence on the assessment, diagnosis and management of SAH. Electronic databases (Medline, PubMed, Google Scholar and Herdin) were searched for relevant literature between 1985 and 2015. A total of 40 articles were obtained and were used to develop the evidence-based clinical algorithm for acute SAH. The clinical algorithm was presented in a one of the conference meeting of the Philippine General Hospital Department of Neurosciences for consensus.
- Open Access
- 21 June 2016
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 7, 96
Clinical Profile and Outcome of Postthymectomy versus Non-Thymectomy Myasthenia Gravis Patients in the Philippine General Hospital: A 6-Year Retrospective Study
Background: Myasthenia gravis is an autoimmune neuromuscular disorder characterized by the production of abnormal autoantibodies directed against the receptors present in the neuromuscular junction. It has been the standard practice to offer thymectomy in all generalized myasthenia gravis patients despite the lack of robust evidence. Objectives: The objectives of this study are to describe the clinical profile and differentiate the clinical outcomes of thymectomy versus non-thymectomy, and thymomatous versus nonthymomatous myasthenia gravis patients in the Philippine General Hospital. Methodology: Between 2009 and 2014, a total of 69 post-thymectomy and 16 nonthymectomy patient records were successfully retrieved. The demographic characteristics, surgical approach and histopathologic results were obtained. The clinical outcome after six months or one year follow-up was also determined and grouped according to the following: 1) complete remission, 2) pharmacological remission, 3) no clinical change 4) worsening symptoms and 5) mortality. Results: Majority of patients were females (68.0%) with a mean age of 39.8 years and a mean duration of myasthenic symptoms of 21 months. Using the MGFA classification, 54.1% of patients fell under Class II and 48.2% of them presented with generalized weakness. In this study, 60.8% of post-thymectomy myasthenia gravis patients had either complete remission or pharmacologic remission compared to 12.5% among non-thymectomy patients (p-value <0.001). No significant difference in the clinical outcome was found between thymomatous and non-thymomatous myasthenia gravis after thymectomy (p-value 0.29). Conclusion: This study showed that both thymomatous and non-thymomatous myasthenia gravis patients who underwent thymectomy had a higher incidence of complete stable remission and pharmacologic remission as compared to myasthenia gravis patients who did not undergo thymectomy. Keywords: myasthenia gravis, thymoma, non-thymomatous, thymectomy
- 21 June 2016
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 7, 96
Open AccessClinical Profile and Outcome of Postthymectomy versus Non-Thymectomy Myasthenia Gravis Patients in the Philippine General Hospital: A 6-Year Retrospective Study
Background: Myasthenia gravis is an autoimmune neuromuscular disorder characterized by the production of abnormal autoantibodies directed against the receptors present in the neuromuscular junction. It has been the standard practice to offer thymectomy in all generalized myasthenia gravis patients despite the lack of robust evidence. Objectives: The objectives of this study are to describe the clinical profile and differentiate the clinical outcomes of thymectomy versus non-thymectomy, and thymomatous versus nonthymomatous myasthenia gravis patients in the Philippine General Hospital. Methodology: Between 2009 and 2014, a total of 69 post-thymectomy and 16 nonthymectomy patient records were successfully retrieved. The demographic characteristics, surgical approach and histopathologic results were obtained. The clinical outcome after six months or one year follow-up was also determined and grouped according to the following: 1) complete remission, 2) pharmacological remission, 3) no clinical change 4) worsening symptoms and 5) mortality. Results: Majority of patients were females (68.0%) with a mean age of 39.8 years and a mean duration of myasthenic symptoms of 21 months. Using the MGFA classification, 54.1% of patients fell under Class II and 48.2% of them presented with generalized weakness. In this study, 60.8% of post-thymectomy myasthenia gravis patients had either complete remission or pharmacologic remission compared to 12.5% among non-thymectomy patients (p-value <0.001). No significant difference in the clinical outcome was found between thymomatous and non-thymomatous myasthenia gravis after thymectomy (p-value 0.29). Conclusion: This study showed that both thymomatous and non-thymomatous myasthenia gravis patients who underwent thymectomy had a higher incidence of complete stable remission and pharmacologic remission as compared to myasthenia gravis patients who did not undergo thymectomy. Keywords: myasthenia gravis, thymoma, non-thymomatous, thymectomy
- Open Access
- 30 November 2013
- Published by Journal of the ASEAN Federation of Endocrine Societies (JAFES) in Journal of the ASEAN Federation of Endocrine Societies
- Vol. 28 (2) , 134-142
Adherence to Self-Care Behavior in Patients Diagnosed with Type 2 Diabetes Mellitus in the Outpatient Department of the Philippine General Hospital
Adherence to Self-Care Behavior in Patients Diagnosed with Type 2 Diabetes Mellitus in the Outpatient Department of the Philippine General Hospital
- 30 November 2013
- Published by Journal of the ASEAN Federation of Endocrine Societies (JAFES) in Journal of the ASEAN Federation of Endocrine Societies
- Vol. 28 (2) , 134-142
Open AccessAdherence to Self-Care Behavior in Patients Diagnosed with Type 2 Diabetes Mellitus in the Outpatient Department of the Philippine General Hospital
Adherence to Self-Care Behavior in Patients Diagnosed with Type 2 Diabetes Mellitus in the Outpatient Department of the Philippine General Hospital